Skip to main content
. Author manuscript; available in PMC: 2011 Feb 1.
Published in final edited form as: Leuk Lymphoma. 2008 May;49(5):852–863. doi: 10.1080/10428190801895352

Table I.

FLT3 inhibitors in publication.

CEP-701(Lestaurtinib) [52]
PKC412(Midostaurin) [53]
SU11248(Sunitinib) [54]
SU5416(Semaxinib) [55]
MLN518(Tandutinib) [56]
AG1295 [57]
AG1296 [58]
SU14813 [59]
ABT869 [60]
KRN383 [61]
KP372-1 [62]
SU5614 [55]
SU11657 [63]
CHIR-258 [64]
Ki23819 [65]
AGL-2043 [66]
AGL-2033 [66]
GTP-14564 [67]
D64406 [68]
R406 [69]
BAY43-9006(Sorafenib) [70]
AS602868 [71]
FI-700 [72]
KW-2449 [73]